Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score

AIMS: Deciding to stop or continue anticoagulation for venous thromboembolism (VTE) after initial treatment is challenging, as individual risks of recurrence and bleeding are heterogeneous. The present study aimed to develop and externally validate models for predicting 5-year risks of recurrence an...

Descripción completa

Detalles Bibliográficos
Autores principales: de Winter, Maria A, Büller, Harry R, Carrier, Marc, Cohen, Alexander T, Hansen, John-Bjarne, Kaasjager, Karin A H, Kakkar, Ajay K, Middeldorp, Saskia, Raskob, Gary E, Sørensen, Henrik T, Visseren, Frank L J, Wells, Philip S, Dorresteijn, Jannick A N, Nijkeuter, Mathilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079391/
https://www.ncbi.nlm.nih.gov/pubmed/36648242
http://dx.doi.org/10.1093/eurheartj/ehac776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079391/
https://www.ncbi.nlm.nih.gov/pubmed/36648242
http://dx.doi.org/10.1093/eurheartj/ehac776

Ejemplares similares